PRESS RELEASE: Lead investor Venrock joined by Andera, Cormorant, HBM Healthcare Investments, Fresenius Medical Care Ventures GmbH, Sofinnova Partners, Apple Tree Partners and MedImmune Corvidia nears completion of its Phase 2 genetically-defined clinical trial targeting chronic kidney disease Funding supports innovative approach to drug developmen…Read More